Three federal categories that actually matter
Almost everything you'll read about a compound's legality comes down to which of these three buckets it falls into, federally. Each Codex profile's "Legal & approval status" field tells you which bucket applies.
1. FDA-approved, prescription required
The compound has gone through FDA review and has an approved label for a specific use. It's fully legal to possess and use — with a valid prescription from a licensed provider, for the approved use. Using someone else's prescription, or using it for an unapproved purpose without a provider's involvement, moves it out of this safe category.
2. DEA-scheduled (controlled substance)
Some compounds — testosterone and its esters are the main ones in the Codex — are separately classified by the DEA as controlled substances (testosterone is Schedule III). This adds a real federal criminal-law layer on top of FDA status: possessing a scheduled substance without a valid prescription is a federal crime under 21 U.S.C. § 844, independent of state law. A first offense carries up to one year in prison and a minimum $1,000 fine; penalties escalate substantially for repeat offenses. This is a real, enforced law, not a technicality.
3. Not FDA-approved, not DEA-scheduled
This is where most of the Codex's investigational and "bioregulator" compounds sit. There's no specific federal crime for simple personal possession of an unscheduled substance. But that is not the same as "fully legal to sell and use" — see below.
The "research chemical" label isn't a shield for you
You'll see peptides sold as "for laboratory research only, not for human consumption." That disclaimer exists for a specific legal reason: introducing an unapproved new drug into commerce for human use violates the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 331) — a real federal law that FDA actively enforces with warning letters and seizures against sellers marketing peptides this way.
The "research chemical" label is a liability shield for the seller — a claim that they're not marketing it as a drug, so the FDCA's drug provisions theoretically don't apply to their sale. It was never designed to protect you. The moment a product is actually used in a human, the seller's paperwork doesn't change what it is, and buying from a seller who is themselves violating federal law by selling it for that exact purpose is not a clean, risk-free position — even where there's no specific statute criminalizing your personal possession of that substance.
Compounding pharmacies are a fourth, separate track
Some peptides that fail the tests above can still legally reach patients through a licensed compounding pharmacy, under Sections 503A/503B of the FDCA — but only for substances the FDA has cleared for compounding via its bulk drug substances review process. This list changes: the FDA restructured the whole system in January 2025, and individual substances move on and off it as new safety data or advisory-committee reviews come in (see the Codex entry for DSIP for a real, current example of a compound whose compounding status has changed multiple times since 2023). A compounding pharmacy being willing to sell you something is not the same as the FDA having approved it — check the compound's actual current status, not just whether someone will sell it to you.
State law can add restrictions federal law doesn't
Everything above is federal law, which applies everywhere in the U.S. States can layer on additional restrictions federal law doesn't have — some states have their own controlled-substance analog acts that sweep more broadly than the DEA schedules, and telehealth/prescribing rules vary by state. Peptera doesn't attempt to track this state-by-state — that's a genuinely large, fast-changing body of law, and getting it wrong would be worse than not covering it. For your specific state:
- Your state's Board of Pharmacy or equivalent regulatory board.
- Your state Attorney General's consumer-protection or controlled-substances pages.
- A licensed attorney, for anything with real stakes.
How to check a specific compound
Every profile in the Codex has a "Legal & approval status" field describing exactly which of the categories above applies, with sources. The Research page also auto-syncs FDA safety alerts and press releases, so real regulatory changes (like new approvals or compounding restrictions) show up there as they happen.